HoldingsChannel.com
EMR insider buying image
The table below summarizes the most recent EMR insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why EMR insider buys are important for investors to follow.
DateInsiderPriceAmount
11-17-2023
Insider Buy
Surendralal Lanca Karsanbhai
President & CEO
$88.20
CAGR »
$881,963.00
10,000 shares
11-8-2023
Insider Buy
William H. Easter III
Director
$84.79
CAGR »
$245,895.35
2,900 shares
11-9-2023
Insider Buy
James Morgan McKelvey Jr.
$85.50
CAGR »
$684,000.00
8,000 shares
11-9-2023
Insider Buy
Joshua B. Bolten
Director
$85.53
CAGR »
$42,766.35
500 shares
3-11-2008
Insider Buy
Technologies Inc Aperture
Director
$50.00
CAGR »
$50,000,000.00
1,000,000 shares
3-10-2020
Insider Buy
Arthur F. Golden
Director
$51.47
CAGR »
$257,346.00
5,000 shares
11-15-2019
Insider Buy
Mark A. Blinn
Director
$73.11
CAGR »
$102,357.64
1,400 shares
5-3-2012
Insider Buy
August A. Busch III
Director
$49.30
CAGR »
$497,928.99
10,100 shares
8-11-2011
Insider Buy
Arthur F. Golden
Director
$43.31
CAGR »
$129,930.00
3,000 shares
8-8-2011
Insider Buy
August A. Busch III
Director
$44.01
CAGR »
$997,232.61
22,660 shares
8-5-2011
Insider Buy
Carlos Fernandez Gonzalez
Director
$45.78
CAGR »
$999,015.61
21,820 shares
8-5-2011
Insider Buy
William R. Johnson
Director
$47.00
CAGR »
$47,000.00
1,000 shares
6-16-2011
Insider Buy
Arthur F. Golden
Director
$52.41
CAGR »
$104,819.40
2,000 shares
5-16-2011
Insider Buy
Craig W. Ashmore
Exec. VP - Planning & Develop.
$53.29
CAGR »
$106,578.00
2,000 shares

Also See: Institutional Holders of EMR
Also See: SEC filings

EMR Performance Since Insider Purchase
Below we present the annualized performance delivered by EMR stock since 11-17-2023 (the date of the most recent insider purchase). The performance of the investment from the time EMR insider buying occurred is the ultimate test of whether insiders were right about EMR being a good buy.

Growth of $10,000.00
With Dividends Reinvested

Start date: 11/20/2023
End date: 04/22/2024
Start price/share: $88.79
End price/share: $108.63
Starting shares: 112.63
Ending shares: 113.18
Dividends reinvested/share: $0.53
Total return: 22.95%
Annualized Gain: 54.76%
Starting investment: $10,000.00
Ending investment: $12,295.00
Years: 0.42
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/20/2023
End date: 04/22/2024
Start price/share: $88.79
End price/share: $108.63
Dividends collected/share: $0.53
Total return: 22.94%
Annualized Gain: 54.72%
Starting investment: $10,000.00
Ending investment: $12,294.00
Years: 0.42

EMR Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent EMR insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding EMR

Quotes delayed 20 minutes

Email EnvelopeFree EMR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the EMR Insider Buying occurred are:

CHEF Insider Buying
KRUS Insider Buying
OSUR Insider Buying
PRFT Insider Buying
NG Insider Buying
GCI Insider Buying
TSHA Insider Buying
AQMS Insider Buying
IVP Insider Buying
ALGM Insider Buying

EMR Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.